HALO
Halozyme Therapeutics, Inc. · Healthcare
President and CEO Helen Torley sold $3.5M of Halozyme Therapeutics, Inc.
Sold$3,476,157
$69.52Price
50,000Shares
−6%Stake
What HALO did after the filing
- The stock from Thu, Mar 5 open, $69.12
- +0.2%
- S&P 500, same days
- +4.1%
Measured over 30 trading days, to the Apr 17 close.
Traded Mon, Mar 2. Filed Wed, Mar 4, 6:56 PM ET, after the close. Returns use the Mar 5 open and the Apr 17 close. Not investment advice.